Ipca Laboratories gets USFDA nod for oral solid dosage formulations facilities

20 Jul 2012 Evaluate

Ipca Laboratories has received the US Food and Drug Administration (USFDA) approval for its oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur in Madhya Pradesh. This approval will enable the company to commercialize more oral solid dosage formulations in the US market.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1310.90 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.